6 completed. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow trafermin: new trials by email Literature Review of trafermin trials Research Report on trafermin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study Trafermin 0.01% spray - Diabetic Foot Ulcer of Neuropathic Origin | Phase 3 | Completed | Olympus Biotech Corporation | 207 | 2010-12-01 | 2014-08-05 |
| The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study Trafermin 0.01% spray - Diabetic Foot Ulcer of Neuropathic Origin | Phase 3 | Completed | Olympus Biotech Corporation | 201 | 2010-11-01 | 2014-08-05 |
| A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3) Trafermin - Periodontitis | Phase 3 | Completed | Kaken Pharmaceutical | 25 | 2009-11-01 | 2013-10-21 |
| Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin) Trafermin (genetical recombination), Placebo - Periodontitis, Alveolar Bone Loss | Phase 3 | Completed | Kaken Pharmaceutical | 328 | 2008-08-01 | 2012-06-15 |
| A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan Trafermin (genetical recombination) - Periodontitis | Phase 2 | Completed | Kaken Pharmaceutical | 267 | 2005-08-01 | 2008-02-05 |
| Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2 Trafermin (genetical recombinant of human basic Fibroblast Growth Factor) - Periodontitis | Phase 2 | Completed | Kaken Pharmaceutical | 91 | 2001-12-01 | 2007-08-10 |
Periodontitis (4) · Diabetic Foot (2) · Wounds and Injuries (2) · Alveolar Bone Loss (1) · Periodontal Attachment Loss (1)
Kaken Pharmaceutical (4) · Olympus Biotech Corporation (2)
Japan (3) · Hungary (2) · Belgium (1) · Bulgaria (1) · Croatia (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Poland (1) · Slovakia (1) · Sweden (1)
Chikara Ieda (2) · Jean-Charles Kerihuel, MD (2) · Makoto Tamura, Ph.D (2)